4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0001140361-23-002783
Chief Financial Officer sold 30,000 shares at $35.00 ($1,050,000)
- Chief Financial Officer acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cummings Keith Lamont Chief Financial Officer | 2023-01-23 | Option exercise | +12,500 | $2.08 | $26,000 | 96,924 | D: show line 1 in the form |
| Cummings Keith Lamont Chief Financial Officer | 2023-01-23 | Option exercise | +17,500 | $6.22 | $108,850 | 114,424 | D: show line 2 in the form |
| Cummings Keith Lamont Chief Financial Officer | 2023-01-23 | Sale | −30,000 | $35.00 | $1,050,000 | 84,424 | D: show line 3 in the form |
| Open-market sales · 30,000 sh · avg $35.00 · $1,050,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cummings Keith Lamont Chief Financial Officer | 2023-01-23 | Option exercise · Stock Option (right to buy) | −12,500 | 133,597 | D: show line 4 in the form | ||
| Cummings Keith Lamont Chief Financial Officer | 2023-01-23 | Option exercise · Stock Option (right to buy) | −17,500 | 18,198 | D: show line 5 in the form |
Loading xslF345X03/form4.xml…